Care Delivery and Regulatory Policy

ABSTRACTS

*Duke authors bolded

Vishal Vashistha, MD, a Duke medical oncology fellow, is first author of "Barriers to prescribing targeted therapies for NSCLC patients with highly actionable gene variants in the VA National Precision Oncology Program" (Abstract 2005) He will deliver an oral presentation on the study at the Care Delivery and Regulatory Policy Session May 29. Per the study abstract conclusions: "A substantial minority of patients with advanced NSCLC bearing highly-actionable gene variants are not prescribed available targeted agents. Further provider- and pathologist-directed educational effort are needed, as well as implementation of health informatics systems to provide near real-time decision support for test ordering and interpretation."
AUTHOR(S) Vishal Vashistha, Jenna Armstrong, David Winski, Meghan Price, Bradley J. Hintze, Pradeep Poonnen, Jane Snowdon, Gretchen Purcell Jackson, Dilhan Weeraratne, David Brotman, Neil L. Spector, Michael J. Kelley


ApricityRx companion digital therapeutic for evidence-based mitigation and phenotype-linked molecular characterization of irAEs in patients receiving immune checkpoint therapy (ICT).
SESSION
Care Delivery and Regulatory Policy
AUTHOR(S)
Matthew T Campbell, Tian Zhang, Lynda Chin, Allison Betof Warner, Matthen Mathew
ABSTRACT / POSTER TPS2089 ● 81

Multi-institutional comparative effectiveness of advanced cancer longitudinal imaging response evaluation methods: Current practice versus artificial intelligence-assisted.
SESSION
Care Delivery and Regulatory Policy
AUTHOR(S)
Andrew Dennis Smith, Brian C. Allen, Asser Abou Elkassem, Rafah Mresh, Seth T. Lirette, Yujan Shrestha, J. David Giese, Reece Stevens, Dillon Williams, Ahmed Farag, Ahmed Khalaf
ABSTRACT / POSTER 2010 ● 2

Changes in cancer mortality rates after the adoption of the Affordable Care Act.
SESSION
Care Delivery and Regulatory Policy
AUTHOR(S)
Anna Lee, Kanan Shah, Junzo P. Chino, Fumiko Chino
ABSTRACT 2003

Out-of-pocket cost of screening with breast MRI for women at high risk for breast cancer.
SESSION
Care Delivery and Regulatory Policy
AUTHOR(S)
I-Wen Pan, Kevin C. Oeffinger, Ya-Chen T. Shih; University of Texas MD Anderson Cancer Center, Houston, TX; Duke University, Durham, NC; The University of Texas MD Anderson Cancer Center, Houston, TX
ABSTRACT / POSTER 2017 ● 9

Optimizing cancer care using digital technologies requires coordinated multi-stakeholder effort.
SESSION
Publication Only: Care Delivery and Regulatory Policy
AUTHOR(S)
Sendhilnathan Ramalingam, A Jay Holmgren, Jennifer Goldsack, Adam Conner-Simons, Edmondo Robinson
ABSTRACT e14108